Pembrolizumab plus enzalutamide and androgen deprivation therapy versus placebo plus enzalutamide and androgen deprivation therapy for metastatic hormone-sensitive prostate cancer: the randomized, double-blind, phase III KEYNOTE-991 study.

Gratzke C., Özgüroğlu M., Peer A., Sendur M. A. N., Retz M., Goh J. C., ...Daha Fazla

Annals of oncology : official journal of the European Society for Medical Oncology, cilt.36, ss.964-975, 2025 (SCI-Expanded, Scopus)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası: 36
• Basım Tarihi: 2025
• Doi Numarası: 10.1016/j.annonc.2025.05.008
• Dergi Adı: Annals of oncology : official journal of the European Society for Medical Oncology
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, PASCAL, CAB Abstracts, EMBASE, MEDLINE
• Sayfa Sayıları: ss.964-975
• İstanbul Üniversitesi-Cerrahpaşa Adresli: Hayır